AuthorReader, Jocelyn C
Ory, Eleanor Claire-Higgins
Vitolo, Michele I
Ching, Mc Millan Nicol
Asiedu, Emmanuel B
Jewell, Christopher M
Rao, Gautam G
Webb, Tonya J
Santin, Alessandro D
Martin, Stuart S
Roque, Dana M
MetadataShow full item record
AbstractBackground: The development of chemoresistance to paclitaxel and carboplatin represents a major therapeutic challenge in ovarian cancer, a disease frequently characterized by malignant ascites and extrapelvic metastasis. Microtentacles (McTNs) are tubulin-based projections observed in detached breast cancer cells. In this study, we investigated whether ovarian cancers exhibit McTNs and characterized McTN biology. Methods: We used an established lipid-tethering mechanism to suspend and image individual cancer cells. We queried a panel of immortalized serous (OSC) and clear cell (OCCC) cell lines as well as freshly procured ascites and human ovarian surface epithelium (HOSE). We assessed by Western blot β-tubulin isotype, α-tubulin post-translational modifications and actin regulatory proteins in attached/detached states. We studied clustering in suspended conditions. Effects of treatment with microtubule depolymerizing and stabilizing drugs were described. Results: Among cell lines, up to 30% of cells expressed McTNs. Four McTN morphologies (absent, symmetric-short, symmetric-long, tufted) were observed in immortalized cultures as well as ascites. McTN number/length varied with histology according to metastatic potential. Most OCCC overexpressed class III ß-tubulin. OCCC/OSC cell lines exhibited a trend towards more microtubule-stabilizing post-translational modifications of α-tubulin relative to HOSE. Microtubule depolymerizing drugs decreased the number/length of McTNs, confirming that McTNs are composed of tubulin. Cells that failed to form McTNs demonstrated differential expression of α-tubulin- and actin-regulating proteins relative to cells that form McTNs. Cluster formation is more susceptible to microtubule targeting agents in cells that form McTNs, suggesting a role for McTNs in aggregation. Conclusions: McTNs likely participate in key aspects of ovarian cancer metastasis. McTNs represent a new therapeutic target for this disease that could refine therapies, including intraperitoneal drug delivery.
Keywordclear cell carcinoma
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18012
- Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells.
- Authors: Yoon JR, Whipple RA, Balzer EM, Cho EH, Matrone MA, Peckham M, Martin SS
- Issue date: 2011 Oct
- Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin.
- Authors: Vitolo MI, Boggs AE, Whipple RA, Yoon JR, Thompson K, Matrone MA, Cho EH, Balzer EM, Martin SS
- Issue date: 2013 Apr 25
- Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells.
- Authors: Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, Yoon JR, Ioffe OB, Tuttle KC, Tan M, Martin SS
- Issue date: 2010 Jun 3
- Extracting microtentacle dynamics of tumor cells in a non-adherent environment.
- Authors: Ory EC, Chen D, Chakrabarti KR, Zhang P, Andorko JI, Jewell CM, Losert W, Martin SS
- Issue date: 2017 Dec 19
- Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment.
- Authors: Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS
- Issue date: 2014 Feb 15